Obinutuzumab Combined With Bendamustine in the Treatment of Mature B-cell Lymphoma

NCT06415708 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

134

Enrollment

OTHER

Sponsor class

Conditions

B Cell Lymphoma

Interventions

DRUG: Obinutuzumab Combined With Bendamustine

Sponsor

Institute of Hematology & Blood Diseases Hospital, China